Analyst firms · Morgan Stanley · KOD
Morgan Stanley KOD price target and rating history
Kodiak Sciences Inc (KOD) · Health Care
Morgan Stanley rates Kodiak Sciences Inc (KOD) Equal-Weight with a $17 price target, as of its latest action on Feb 24, 2022. It has published 3 rating actions on KOD since January 2022, including 0 upgrades and 0 downgrades.
- Current rating
- Equal-Weight
- Price target
- $17
- Median target, all firms
- Too few
- Actions on KOD
- 3
Morgan Stanley price target on KOD
Every Morgan Stanley rating on KOD
- Feb 24, 2022
- Feb 1, 2022
- Jan 18, 2022
How other firms rate KOD
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Goldman Sachs | Neutral | $36 | Sep 24, 2026 |
| Chardan Capital Markets | Buy | $61 | May 11, 2026 |
Questions about Morgan Stanley and KOD
- What is Morgan Stanley's price target for KOD?
- Morgan Stanley's latest stated price target for Kodiak Sciences Inc (KOD) is $17, from its action on Feb 24, 2022.
- What is Morgan Stanley's rating on KOD?
- Morgan Stanley rates KOD Equal-Weight, a neutral rating, as of Feb 24, 2022.
- When did Morgan Stanley last change its view on KOD?
- On Feb 24, 2022, Morgan Stanley cuts its price target to $17 from $77, keeps Equal-Weight.
More KOD rating histories
All Morgan Stanley ratingsKOD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.